ClinicalTrials.gg
Not yet recruitingNCT07737145IN-TALKUpdated Nov 6, 2026

IN-TALK: Co-producing a Hospice Intimacy Support Toolkit in England

An observational study in Communication About Intimacy Needs in Hospice and Palliative Care, sponsored by Dorothy House Hospice. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Dorothy House Hospice · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
794
Ages
18 Years and older
Sex
All
01

Study summary

People receiving hospice care may experience concerns about intimacy, closeness and physical affection that can affect their quality of life and wellbeing. However, healthcare professionals often report feeling uncertain about how to initiate or respond to conversations about intimacy needs. This can result in unmet needs and missed opportunities to provide holistic, person-centred care.

The aim of the IN-TALK study is to co-produce a hospice intimacy support toolkit to support healthcare professionals in initiating and responding to conversations about intimacy needs with people receiving hospice care in England.

This prospective mixed methods observational study uses Experience-Based Co-Design (EBCD) as its co-production methodology to develop a hospice intimacy support toolkit. Findings from the surveys will inform a series of co-production workshops involving hospice service users and healthcare professionals. Together, participants will co-produce the content and design of a hospice intimacy support toolkit to support person-centred care in hospice services across England.

Read the detailed description

IN-TALK is a 24-month prospective mixed methods observational study which uses Experience-Based Co-Design (EBCD) as its co-production methodology to develop a hospice intimacy support toolkit. The study is funded by the National Institute for Health and Care Research (NIHR) Research for Patient Benefit (RfPB) Programme (Grant Reference NIHR209649).

The study aims to co-produce an evidence-informed hospice intimacy support toolkit to support healthcare professionals in initiating and responding to conversations about intimacy needs with people receiving hospice care in England.

The study comprises two interconnected work packages. Cross-sectional surveys of hospice service users and healthcare professionals will generate evidence to inform Experience-Based Co-Design (EBCD) workshops, through which participants will co-produce a hospice intimacy support toolkit.

Work Package 1 will undertake cross-sectional surveys of hospice healthcare professionals and hospice service users in England. The surveys will explore experiences of intimacy needs conversations, perceived barriers and facilitators, confidence, education and training needs, and priorities for improving support within hospice care. Survey findings will be analysed using descriptive statistics and qualitative analysis of free-text responses where appropriate.

Work Package 2 will use Experience-Based Co-Design (EBCD) methodology to bring together hospice service users and healthcare professionals in a series of co-production workshops. Workshop participants will review the findings from Work Package 1, identify priorities for improvement and collaboratively design the content, format and implementation considerations for a hospice intimacy support toolkit. Workshops will be delivered in two face-to-face locations and one online workshop to maximise accessibility and participation.

The study will produce a hospice intimacy support toolkit intended to support healthcare professionals to address intimacy needs as part of holistic, person-centred hospice care. No investigational medicinal products, medical devices or experimental interventions will be evaluated. Participants will continue to receive usual hospice care throughout the study.

02

Conditions studied

  • Communication About Intimacy Needs in Hospice and Palliative Care

Browse trials for

Keywords

  • Hospice care
  • Palliative care
  • Intimacy
  • Communication
  • Co-production
  • Mixed methods
  • Healthcare professionals
  • Education
  • Training
  • Person-centred care
  • Support toolkit
  • Hospice service users
  • Holistic care
03

In context

Communication

719 studies on the registry are indexed under Communication; 159 are open to participants now.

This study's planned enrollment of 794 is above the median of 104 across 132 observational studies indexed under Communication.

Browse Communication studies →

Lead sponsor

Dorothy House Hospice is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population comprises adult hospice service users (including patients, partners, loved ones and bereaved people receiving palliative and end of life care or support services from hospices in England) and registered and non-registered healthcare professionals working in hospices in England.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Hospice service users: Aged 18 years or over. Hospice service users: Patients, partners, loved ones and bereaved people who are receiving, or have received, care or support services from hospices in England.

Hospice service users: Able to understand and communicate in spoken and written English, independently or with the support of an interpreter.

Hospice service users: Able and willing to provide . Healthcare professionals: Registered or non-registered healthcare professionals currently working within hospices in England involved in patient care and support.

Healthcare professionals: Aged 18 years or over. Healthcare professionals: Able and willing to provide informed consent.

Exclusion criteria

Exclusion Criteria:

Hospice service users: Cognitive impairment that impedes communication. Healthcare professionals: Registered and non-registered Healthcare professionals currently working outside of hospices; and England.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
794 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hospice service users

    Adults receiving hospice care in England who meet the study eligibility criteria and participate in the survey, the Experience-Based Co-Design (EBCD) workshops, or both, to inform the hospice intimacy support toolkit.

    Behavioral: Experience-Based Co-Design (EBCD) workshops

  • Healthcare professionals

    Healthcare professionals working within hospice services in England who meet the study eligibility criteria and participate in the survey, the Experience-Based Co-Design (EBCD) workshops, or both, to inform the hospice intimacy support toolkit.

    Behavioral: Experience-Based Co-Design (EBCD) workshops

Interventions

  • BehavioralExperience-Based Co-Design (EBCD) workshops

    Experience-Based Co-Design (EBCD) workshops are used as a co-production research method to collaboratively develop a hospice intimacy support toolkit with hospice service users and healthcare professionals. The workshops are part of the research methodology and are not a therapeutic or clinical intervention.

06

What researchers measure

Primary outcomes

  1. Priorities for an intimacy support toolkit

    Identification of priorities for the content, format and implementation of a hospice intimacy support toolkit through analysis of survey findings and Experience-Based Co-Design (EBCD) workshop discussions involving hospice service users and healthcare professionals.

    Time frame: Up to 24 months

Secondary outcomes

  1. Hospice service users' intimacy support needs and priorities

    Self-reported intimacy support needs, preferred sources of support, and priorities for hospice intimacy support identified through an e-survey of hospice service users.

    Time frame: During the cross-sectional survey data collection period (anticipated November 2026 to March 2027).

  2. Healthcare professionals' confidence and educational needs

    Self-reported confidence, perceived barriers and facilitators, and education and training needs relating to conversations about intimacy needs identified through an e-survey of hospice healthcare professionals.

    Time frame: During the cross-sectional survey data collection period (anticipated April 2027 to September 2027).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Apr 2028, 17 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2026
First posted
Jul 30, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Apr 30, 2028
CompletionEst.
May 31, 2028
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07737145
Lead sponsor
Dorothy House Hospice
Collaborators
St Oswald's Hospice, University of the West of England, Bristol, National Institute for Health and Care Research
Responsible party
Sponsor
First posted
Jul 30, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Apr 30, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Nov 6, 2026

Study contacts

Dr Kate Sugar
Contact
kate.sugar@dorothyhouse-hospice.org.uk
+44 1225 722988
Dr Kate Sugar
principal investigator · Dorothy House
Professor Candida McCabe
study chair · Dorothy House

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion